CTC Clinical Trial Consultants AB

The trials here

What the 8 trials at this site are about, from their registry records.

Conditions

• Obesity2 trials
• Type 2 diabetes2 trials
• Atopic dermatitis (eczema)1 trial
• Coeliac disease1 trial
• COPD1 trial
• Hepatitis B1 trial
• Migraine1 trial
• Type 1 diabetes1 trial

Phase

• Phase 34 trials
• Phase 23 trials
• Phase 11 trial

Status

• Completed5 trials
• Recruiting2 trials
• Active, not recruiting1 trial

Lead sponsor

• AbbVie1 trial
• AstraZeneca1 trial
• Empros Pharma AB1 trial
• Hoffmann-La Roche1 trial
• Novo Nordisk A/S1 trial
• and 3 more

Running trials

• Recruiting

  A double-blind, randomised, placebo-controlled first-in-human/Phase Ib trial to investigate safety, tolerability, pharmacokinetics, and preliminary efficacy of single and multiple doses of TIR-C 2% cutaneous emulsion in adults with mild to moderate atopic dermatitis

  2026-526343-35-00· Phase 1· Pharmability AB· Source

• Recruiting

  A Study to Evaluate Effect of AZD6234 as an Adjunct to Incretin-based Therapies in Adult Participants With Obesity or Overweight With Weight-related Comorbidity With or Without Type 2 Diabetes Mellitus

  NCT07776509· Phase 3· AstraZeneca· Source

• Active, not recruiting

  A Phase 2a/b Study of the Efficacy and Safety of Subcutaneous Amlitelimab in Adults With Nonresponsive Celiac Disease

  NCT06557772· Phase 2· Sanofi· Source

Recruiting at the same time

How many trials recruit for the same indication here at once. A count, not a rating.

• Atopic dermatitis (eczema)1 recruiting
• Obesity1 recruiting
• Type 1 diabetes1 recruiting
• Type 2 diabetes1 recruiting

Closed trials

• Not yet recruiting

  A Trial With EMP16 in Preparation for Late Phase Studies

  NCT06993428· Phase 2· Empros Pharma AB· Source

• Completed

  Study of Oral Atogepant Tablets to Assess Safety and Efficacy in Adult Participants With Migraine

  NCT06241313· Phase 3· AbbVie· Source

• Completed

  A Research Study to See How Well CagriSema Compared to Semaglutide, Cagrilintide and Placebo Lowers Blood Sugar and Body Weight in People With Type 2 Diabetes Treated With Metformin With or Without an SGLT2 Inhibitor

  NCT06065540· Phase 3· Novo Nordisk A/S· Source

• Completed

  A trial to evaluate safety and characteristics of a substance for treatment of chronic hepatitis

  2023-503880-40-00· Phase 2· Suzhou Ribo Life Science Co. Ltd.· Source

• Completed

  A Study to Evaluate Astegolimab in Participants With Chronic Obstructive Pulmonary Disease

  NCT05595642· Phase 3· Hoffmann-La Roche· Source